A Study Of RPM For Chronic Pain Patients Using Wearable Devices

Overview

About this study

The purpose of this study is to assess the effectiveness of remote monitoring tools in tracking daily pain-related symptoms and related physiological metrics (including heart rate, heart rate variability, sleep length, quality and proportion of REM and nonREM sleep, stress levels, activity scale, skin temperature, calorimetric data). To evaluate changes in clinical outcomes such as pain severity, medication use, and functional status following treatments for chronic pain and their correlation with physiological metrics as measured by wearable device. To assess wearable device study feasibility and patient engagement with remote monitoring in chronic pain patient population.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults aged 18-90 with chronic non-cancer pain who will be deemed candidates and referred for pain medicine procedure (epidural injections, peripheral joint or soft tissue injection, nerve blocks or radiofrequency ablation, neuromodulation) based on clinical evaluation.

  • Receiving outpatient pain management care at our institution.

  • Is willing and able operate a given wearable device.

  • Patient willing to wear provided wearable device for >20 hours/day for period before, during and after pain medicine procedure, up to 7 months.

 

Exclusion Criteria: 

  • Active substance abuse.

  • Severe cognitive impairment.

  • Inability to wear a wearable device.

  • Inability or unwillingness of individual or legal guardian/representative to provide written informed consent.

  • Ongoing litigation related to the pain or workers' compensation claims.

  • Life expectancy less than 12 months due to any cause.

  • Any other condition or circumstance that, in the opinion of the investigator, would make the patient unsuitable for participation in the study or unable to comply with follow-up requirements.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 7/8/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Eva Kubrova

Open for enrollment

Contact information:

Eva Kubrova

(904) 953-8513

kubrova.eva@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20597133

Mayo Clinic Footer